A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

Tirzepatide works by mimicking the glucagon-like peptide-1 (GLP-1 ... Tirzepatide was approved in November 2023 by the US Food and Drug Administration (FDA) (Zepbound) and in the EU in June ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

FDA approves first ... the secretion of a peptide that is known to regulate appetite. The long-awaited approval comes after the FDA's extended review of the drug and mixed results from a late ...

Glucagon-like peptide-1 agonists ... These branded prescription pharmaceuticals – approved by the Food and Drug Administration – are so popular and in demand that pharmaceutical manufacturers ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

GLP-1s refer to compounded glucagon-like peptide 1 ... due to a lack of FDA assessment at points of entry. “These drugs come in formulations that the FDA has never approved, have inconsistent ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Soleno Therapeutics drug Vykat XR has received the first FDA-approval for Prader-Willi ... The product’s list price is $5.92 per mg. Based on the average weight of patients in the clinical ...

Novo Nordisk is expanding its prospects in obesity and other metabolic disorders by securing rights to an early-clinical engineered peptide ... list price for a month’s supply of the drug ...